{"id":3340,"date":"2025-08-10T11:39:45","date_gmt":"2025-08-10T11:39:45","guid":{"rendered":"https:\/\/nano-test.de\/?p=3340"},"modified":"2026-02-20T06:29:57","modified_gmt":"2026-02-20T06:29:57","slug":"ema-leitlinien-zur-entwicklung-von-allergenprodukten","status":"publish","type":"post","link":"https:\/\/nano-test.de\/fr\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/","title":{"rendered":"Lignes directrices de l'EMA pour le d\u00e9veloppement de produits allerg\u00e8nes"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3340\" class=\"elementor elementor-3340\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9640da2 ts-col-stretched-none ts-bg-color-over-image elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9640da2\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-bac4490 ts-bg-color-over-image\" data-id=\"bac4490\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6656108f elementor-widget elementor-widget-text-editor\" data-id=\"6656108f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2><span style=\"color: #000000;\"><strong>Une nouvelle \u00e8re en mati\u00e8re d'immunoth\u00e9rapie et de diagnostic des allergies commence<\/strong><\/span><\/h2><p><span style=\"color: #000000;\">Der Leitfaden mit dem Titel \u201eAllergen Products Development for Immunotherapy and Allergy Diagnosis in Moderate to Low Sized Study Populations\u201d (Entwicklung allergenhaltiger Produkte f\u00fcr die Immuntherapie und Allergiediagnostik in Studien mit mittlerer bis geringer Teilnehmerzahl) wurde von der <a href=\"https:\/\/www.ema.europa.eu\/en\/homepage\">Europ\u00e4ischen Arzneimittelagentur (EMA)<\/a> ver\u00f6ffentlicht und tritt am 1. Januar 2026 in Kraft. Er wurde speziell f\u00fcr Allergietypen mit einer begrenzten Anzahl von Patienten erstellt. Die Bedeutung, den Umfang und die Details dieses Leitfadens werden wir in unserem Blogbeitrag vorstellen.<\/span><\/p><p><span style=\"color: #000000;\">Quelles innovations cette ligne directrice, qui fournit aux chercheurs et aux fabricants des cadres r\u00e9glementaires flexibles pour le d\u00e9veloppement de produits de diagnostic et d'immunoth\u00e9rapie\u00a0? Voici les principaux points\u2026<\/span><\/p><p><span style=\"color: #000000;\"><b>1. Approche flexible pour les types d'allergies \u00e0 faibles patients<\/b><\/span><\/p><p><span style=\"color: #000000;\">La difficult\u00e9 de la recherche clinique dans certains types d'allergies est le point de d\u00e9part de cette ligne directrice. La principale cause de la ligne directrice est la difficult\u00e9 de trouver suffisamment de patients pour des \u00e9tudes sur les allergies rares aux insectes ou les allergies alimentaires.<\/span><\/p><p><span style=\"color: #000000;\">Cependant, l'EMA admet qu'il peut y avoir d'autres moyens dans de tels cas.<\/span><\/p><p><span style=\"color: #000000;\">Les produits allerg\u00e8nes \u00e9num\u00e9r\u00e9s dans les directives comprennent :<\/span><\/p><ul><li><span style=\"color: #000000;\">Syst\u00e8me d'organes affect\u00e9s (p. ex. voies respiratoires sup\u00e9rieures et inf\u00e9rieures, yeux, peau, atteinte de plusieurs organes (r\u00e9action syst\u00e9mique))<\/span><\/li><li><span style=\"color: #000000;\">Source d'alagen agene (p. ex. pollen, acariens, poils d'animaux, moisissures, toxines d'insectes, aliments, produits chimiques),<\/span><\/li><li><span style=\"color: #000000;\">Produit allerg\u00e8ne (extraits, allerg\u00e8nes purifi\u00e9s, allerg\u00e8nes modifi\u00e9s, allerg\u00e8nes adsorb\u00e9s)<\/span><\/li><li><span style=\"color: #000000;\">Ind\u00e9pendamment du type d'application (par exemple, sous-cutan\u00e9, sublingual, oral, percutan\u00e9) Produits allerg\u00e8nes pour l'immunoth\u00e9rapie allerg\u00e8ne pour les allergies de type I et pour le diagnostic des allergies de type I et de type IV<\/span><\/li><\/ul><p><\/p><div style=\"width: 847px;\" class=\"wp-video\"><video class=\"wp-video-shortcode\" id=\"video-3340-1\" width=\"847\" height=\"447\" loop autoplay preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/Hukuki-Zemin-ve-Dogru-Danisma-Stratejisi.mp4?_=1\"><\/source><a href=\"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/Hukuki-Zemin-ve-Dogru-Danisma-Stratejisi.mp4\">https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/Hukuki-Zemin-ve-Dogru-Danisma-Stratejisi.mp4<\/a><\/video><\/div><p><span style=\"color: #000000;\"><b>2. Base juridique et strat\u00e9gie de conseil correcte<\/b><\/span><\/p><p><span style=\"color: #000000;\">Lors de sa publication, la seule demande \u00e9tait jug\u00e9e insuffisante. L'\u00e9valuation, en conjonction avec d'autres lignes directrices de l'EMA, du CHMP et du PCI, facilite la r\u00e9alisation des r\u00e9sultats. Il est important que les fabricants et les chercheurs entrent en contact avec les r\u00e9gulateurs \u00e0 un stade pr\u00e9coce afin de clarifier la strat\u00e9gie de d\u00e9veloppement.<\/span><\/p><p><span style=\"color: #000000;\">Les directives pertinentes sont :<\/span><\/p><ul><li><span style=\"color: #000000;\">Ligne directrice pour les \u00e9tudes cliniques dans les petites populations - CHMP\/EWP\/83561\/2005<\/span><\/li><li><span style=\"color: #000000;\">Ligne directrice sur les donn\u00e9es manquantes dans la confirmation des \u00e9tudes cliniques - EMA\/CPMP\/EWP\/1776\/99 R\u00e9v. 1<\/span><\/li><li><span style=\"color: #000000;\">Ligne directrice pour l'ajustement des valeurs de r\u00e9f\u00e9rence dans les \u00e9tudes cliniques - EMA\/CHMP\/295050\/2013<\/span><\/li><li><span style=\"color: #000000;\">Ligne directrice sur les principes statistiques des \u00e9tudes cliniques - CPMP\/ICH\/363\/96<\/span><\/li><li><span style=\"color: #000000;\">I E9 (R1) - Annexe \u00e0 la directive sur les principes statistiques pour les \u00e9tudes cliniques : estimations et analyse de sensibilit\u00e9 dans les \u00e9tudes cliniques - EMA\/CHMP\/ICH\/436221\/2017<\/span><\/li><li><span style=\"color: #000000;\">Lignes directrices pour la s\u00e9lection du groupe t\u00e9moin dans les \u00e9tudes cliniques - CPMP\/ICH\/364\/96 \u2022 Lignes directrices d'\u00e9valuation clinique - CPMP\/EWP\/1119\/98\/Rev. 1<\/span><\/li><li><span style=\"color: #000000;\">Ligne directrice sur le d\u00e9veloppement clinique de produits d'immunoth\u00e9rapie sp\u00e9cifiques pour le traitement des maladies allergiques - CHMP\/EWP\/18504\/2006<\/span><\/li><li><span style=\"color: #000000;\">Ligne directrice sur les produits allerg\u00e8nes : Directives sur les questions de fabrication et de qualit\u00e9 - EMEA\/CHMP\/BWP\/304831\/2007<\/span><\/li><li><span style=\"color: #000000;\">\u2022 Ligne directrice pour la validation des processus pour les m\u00e9dicaments finis - Informations et donn\u00e9es \u00e0 soumettre dans les demandes d'approbation - EMA\/CHMP\/CVMP\/BWP\/70278\/2012-REV1, Corr.1<\/span><\/li><li><span style=\"color: #000000;\">Recommandations pour des approches r\u00e9glementaires communes pour les produits allerg\u00e8nes \u2013 CMDH\/399\/2019<\/span><\/li><\/ul><p><span style=\"color: #000000;\"><b>3. Flexibilit\u00e9 dans les \u00e9tudes de qualit\u00e9 et non cliniques<\/b><\/span><\/p><p><span style=\"color: #000000;\">Les cat\u00e9gories d'allerg\u00e8nes contenues dans les directives sont les suivantes.<\/span><\/p><ul><li><span style=\"color: #000000;\">Allergene f\u00fcr diagnostische Zwecke in <a href=\"https:\/\/nano-test.de\/en\/research\/in-vivo-tests\/\">Tests in vivo<\/a>: Typ I (Pricktest, Provokationstest, intradermaler\/intrakutaner Test) und Typ IV (epikutaner Patch-Test)<\/span><\/li><li><span style=\"color: #000000;\">Allerg\u00e8ne-immunoth\u00e9rapie - AIT (allerg\u00e8nes inhal\u00e9s, allerg\u00e8nes d'insectes, allerg\u00e8nes alimentaires).<\/span><\/li><\/ul><p><span style=\"color: #000000;\">Si des tests de laboratoire standard ou des \u00e9tudes non cliniques compl\u00e8tes ne peuvent pas \u00eatre men\u00e9s dans ces cat\u00e9gories, des m\u00e9thodes alternatives telles que la recherche documentaire et les opinions d'experts peuvent \u00eatre accept\u00e9es. Cette approche vise \u00e0 aider \u00e0 acc\u00e9l\u00e9rer le processus de d\u00e9veloppement dans les petites populations.<\/span><\/p><p><span style=\"color: #000000;\"><b>4. Utilisation de sources de donn\u00e9es alternatives<\/b><\/span><\/p><p><span style=\"color: #000000;\">In allergologischen Studien mit geringer Patientenzahl k\u00f6nnen retrospektive Daten, Fallberichte und die Verwendung von Produkten f\u00fcr \u201ebenannte Patienten\u201d als unterst\u00fctzende Daten herangezogen werden. Der Leitfaden betont, dass alternative Metriken wie <b>PR (Positivit\u00e4tsrate)<\/b> et <b>RI (Reaktionsindex)<\/b> bei der Beurteilung der diagnostischen Genauigkeit eine Rolle spielen.<\/span><\/p><p><span style=\"color: #000000;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignleft\" src=\"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/Eine-neue-Ara-in-der-Immuntherapie-und-Allergiediagnose-beginnt-200x300.jpg\" alt=\"\" width=\"200\" height=\"300\">Mit diesem Leitfaden der EMA wird eine neue Regelung f\u00fcr Allergenproduktstudien mit einer geringen Anzahl von Patienten eingef\u00fchrt. Dank flexibler Datenquellen, alternativer klinischer Designs und Anpassungen in den Qualit\u00e4tsprozessen wird die Entwicklung von Diagnose- und Behandlungsoptionen f\u00fcr <b>seltene Allergietypen<\/b> erleichtert.<\/span><\/p><p><span style=\"color: #000000;\">Pour plus d'informations, consultez les directives \u00e0 l'adresse : https:\/\/www.ema.europa.eu\/fr\/documents\/scientific-guideline\/guideline-allergen-products . -d\u00e9veloppement-immunoth\u00e9rapie-allergie-diagnostic-mod\u00e9r\u00e9-faible-\u00e9tude-population_fr.pdf<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bb8812e ts-col-stretched-none ts-bg-color-over-image elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bb8812e\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4c314d0 ts-bg-color-over-image\" data-id=\"4c314d0\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-abfd8b0 elementor-widget elementor-widget-html\" data-id=\"abfd8b0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"VideoObject\",\n  \"name\": \"EMA-Leitlinien zur Entwicklung von Allergenprodukten\",\n  \"description\": \"Dieses Video erkl\u00e4rt die regulatorischen Anforderungen und Strategien gem\u00e4\u00df den EMA-Leitlinien zur Entwicklung von Allergenprodukten, einschlie\u00dflich rechtlicher Grundlagen und wissenschaftlicher Beratung.\",\n  \"thumbnailUrl\": \"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/EMA-Leitlinien-zur-Entwicklung-von-Allergenprodukten.jpg\",\n  \"uploadDate\": \"2025-08-10T00:00:00+00:00\",\n  \"contentUrl\": \"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/Hukuki-Zemin-ve-Dogru-Danisma-Stratejisi.mp4\",\n  \"embedUrl\": \"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/\"\n}\n<\/script>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Eine neue \u00c4ra in der Immuntherapie und Allergiediagnostik beginnt Der Leitfaden mit dem Titel \u201eAllergen Products Development for Immunotherapy and Allergy Diagnosis in Moderate to Low Sized Study Populations\u201d (Entwicklung allergenhaltiger Produkte f\u00fcr die Immuntherapie und Allergiediagnostik in Studien mit mittlerer bis geringer Teilnehmerzahl) wurde von der Europ\u00e4ischen Arzneimittelagentur (EMA) ver\u00f6ffentlicht und tritt am 1. \u2026 <a href=\"https:\/\/nano-test.de\/fr\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/\" class=\"more-link\" title=\"Continue reading &lt;span class=\" screen-reader-text>EMA Guidelines for the Development of Allergen Products\u00ab\u00a0&gt;Continue reading <span class=\"screen-reader-text\">Lignes directrices de l'EMA pour le d\u00e9veloppement de produits allerg\u00e8nes<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":3341,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-3340","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EMA Guidelines for the Development of Allergen Products | Nano-Test\u00ae<\/title>\n<meta name=\"description\" content=\"Der neue Leitfaden der EMA bietet einen Fahrplan f\u00fcr Studien in kleinem bis mittlerem Ma\u00dfstab bei der Entwicklung von Allergenprodukten und Diagnostika.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMA Guidelines for the Development of Allergen Products | Nano-Test\u00ae\" \/>\n<meta property=\"og:description\" content=\"Der neue Leitfaden der EMA bietet einen Fahrplan f\u00fcr Studien in kleinem bis mittlerem Ma\u00dfstab bei der Entwicklung von Allergenprodukten und Diagnostika.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/\" \/>\n<meta property=\"og:site_name\" content=\"Nano-Test\u00ae\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-10T11:39:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-20T06:29:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sultan Culum\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sultan Culum\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/\"},\"author\":{\"name\":\"Sultan Culum\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/person\\\/e873a4aee4023b424d94f10e41a12670\"},\"headline\":\"EMA Guidelines for the Development of Allergen Products\",\"datePublished\":\"2025-08-10T11:39:45+00:00\",\"dateModified\":\"2026-02-20T06:29:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/\"},\"wordCount\":679,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png\",\"articleSection\":[\"Pharma\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/\",\"url\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/\",\"name\":\"EMA Guidelines for the Development of Allergen Products | Nano-Test\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png\",\"datePublished\":\"2025-08-10T11:39:45+00:00\",\"dateModified\":\"2026-02-20T06:29:57+00:00\",\"description\":\"Der neue Leitfaden der EMA bietet einen Fahrplan f\u00fcr Studien in kleinem bis mittlerem Ma\u00dfstab bei der Entwicklung von Allergenprodukten und Diagnostika.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png\",\"contentUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png\",\"width\":750,\"height\":450,\"caption\":\"Nano-Test.de erkl\u00e4rt die EMA-Guidelines f\u00fcr Allergenprodukte, einschlie\u00dflich Qualit\u00e4tsanforderungen, Sicherheitsbewertung und regulatorischer Compliance zur sicheren Produktentwicklung\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2025\\\/08\\\/10\\\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nano-test.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EMA Guidelines for the Development of Allergen Products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#website\",\"url\":\"https:\\\/\\\/nano-test.de\\\/\",\"name\":\"NANO-TEST\u00ae\",\"description\":\"Laboranalysen, Testservices, Pr\u00fcflabor &amp; Qualit\u00e4tskontrollen in Deutschland\",\"publisher\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nano-test.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#organization\",\"name\":\"NANO-TEST\u00ae\",\"url\":\"https:\\\/\\\/nano-test.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Nanotest-Logo-NT-scaled.png\",\"contentUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Nanotest-Logo-NT-scaled.png\",\"width\":2510,\"height\":2560,\"caption\":\"NANO-TEST\u00ae\"},\"image\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/person\\\/e873a4aee4023b424d94f10e41a12670\",\"name\":\"Sultan Culum\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g\",\"caption\":\"Sultan Culum\"},\"sameAs\":[\"https:\\\/\\\/nano-test.de\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Directives de l'EMA pour le d\u00e9veloppement de produits allerg\u00e8nes | Nano-test\u00ae","description":"Le nouveau guide de l'EMA fournit une feuille de route pour les petites et moyennes \u00e9tudes dans le d\u00e9veloppement de produits et de diagnostics allerg\u00e8nes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/","og_locale":"fr_FR","og_type":"article","og_title":"EMA Guidelines for the Development of Allergen Products | Nano-Test\u00ae","og_description":"Der neue Leitfaden der EMA bietet einen Fahrplan f\u00fcr Studien in kleinem bis mittlerem Ma\u00dfstab bei der Entwicklung von Allergenprodukten und Diagnostika.","og_url":"https:\/\/nano-test.de\/fr\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/","og_site_name":"Nano-Test\u00ae","article_published_time":"2025-08-10T11:39:45+00:00","article_modified_time":"2026-02-20T06:29:57+00:00","og_image":[{"width":750,"height":450,"url":"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png","type":"image\/png"}],"author":"Sultan Culum","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Sultan Culum","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#article","isPartOf":{"@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/"},"author":{"name":"Sultan Culum","@id":"https:\/\/nano-test.de\/#\/schema\/person\/e873a4aee4023b424d94f10e41a12670"},"headline":"EMA Guidelines for the Development of Allergen Products","datePublished":"2025-08-10T11:39:45+00:00","dateModified":"2026-02-20T06:29:57+00:00","mainEntityOfPage":{"@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/"},"wordCount":679,"commentCount":0,"publisher":{"@id":"https:\/\/nano-test.de\/#organization"},"image":{"@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#primaryimage"},"thumbnailUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png","articleSection":["Pharma"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Commentaire","target":["https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/","url":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/","name":"Directives de l'EMA pour le d\u00e9veloppement de produits allerg\u00e8nes | Nano-test\u00ae","isPartOf":{"@id":"https:\/\/nano-test.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#primaryimage"},"image":{"@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#primaryimage"},"thumbnailUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png","datePublished":"2025-08-10T11:39:45+00:00","dateModified":"2026-02-20T06:29:57+00:00","description":"Le nouveau guide de l'EMA fournit une feuille de route pour les petites et moyennes \u00e9tudes dans le d\u00e9veloppement de produits et de diagnostics allerg\u00e8nes.","breadcrumb":{"@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#primaryimage","url":"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png","contentUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2025\/08\/EMAdan-Kucuk-Calisma-Gruplari-Icin-Alerjen-Urun-Gelistirme-Rehberi.png","width":750,"height":450,"caption":"Nano-test.de explique les directives de l'EMA pour les produits allerg\u00e8nes, y compris les exigences de qualit\u00e9, l'\u00e9valuation de la s\u00e9curit\u00e9 et la conformit\u00e9 r\u00e9glementaire pour le d\u00e9veloppement de produits s\u00e9curitaires"},{"@type":"BreadcrumbList","@id":"https:\/\/nano-test.de\/2025\/08\/10\/ema-leitlinien-zur-entwicklung-von-allergenprodukten\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/nano-test.de\/"},{"@type":"ListItem","position":2,"name":"Lignes directrices de l'EMA pour le d\u00e9veloppement de produits allerg\u00e8nes"}]},{"@type":"WebSite","@id":"https:\/\/nano-test.de\/#website","url":"https:\/\/nano-test.de\/","name":"NANO-TEST\u00ae","description":"Analyses en laboratoire, services d'essais, laboratoire d'essais et contr\u00f4les qualit\u00e9 en Allemagne","publisher":{"@id":"https:\/\/nano-test.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nano-test.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nano-test.de\/#organization","name":"NANO-TEST\u00ae","url":"https:\/\/nano-test.de\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nano-test.de\/#\/schema\/logo\/image\/","url":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/03\/Nanotest-Logo-NT-scaled.png","contentUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/03\/Nanotest-Logo-NT-scaled.png","width":2510,"height":2560,"caption":"NANO-TEST\u00ae"},"image":{"@id":"https:\/\/nano-test.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nano-test.de\/#\/schema\/person\/e873a4aee4023b424d94f10e41a12670","name":"Sultan Culum","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g","caption":"Sultan Culum"},"sameAs":["https:\/\/nano-test.de"]}]}},"_links":{"self":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/posts\/3340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/comments?post=3340"}],"version-history":[{"count":0,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/posts\/3340\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/media\/3341"}],"wp:attachment":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/media?parent=3340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/categories?post=3340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/tags?post=3340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}